High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation

@article{AsanoMori2005HighgradeCA,
  title={High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation},
  author={Yuki Asano-Mori and Kumi Oshima and Mamiko Sakata-Yanagimoto and Masahiro Nakagawa and Koji Kandabashi and Koji Izutsu and Akira Hangaishi and Toru Motokura and Shigeru Chiba and Mineo Kurokawa and Hisamaru Hirai and Yoshinobu Kanda},
  journal={Bone Marrow Transplantation},
  year={2005},
  volume={36},
  pages={813-819}
}
Summary:Clinical impact of high-grade (HG) cytomegalovirus (CMV) antigenemia after hematopoietic stem cell transplantation has not been clarified. Therefore, in order to investigate the risk factors and outcome for HG-CMV antigenemia, we retrospectively analyzed the records of 154 Japanese adult patients who underwent allogeneic hematopoietic stem cell transplantation for the first time from 1995 to 2002 at the University of Tokyo Hospital. Among 107 patients who developed positive CMV… CONTINUE READING